Extended interval dosing of natalizumab: A two-center, 7-year experience

Authors
Category Primary study
JournalTherapeutic Advances in Neurological Disorders
Year 2014
This article has no abstract
Epistemonikos ID: ca7f8bd1958e0d85cc66ecc5958403d79ef52064
First added on: Feb 06, 2025